Arbor launches GLP-1 plans starting at $99 a month
The telehealth offering undercuts typical compounded and branded incretin pricing in the direct-to-consumer channel.
DO
By Daniel Okafor · Regulatory Correspondent
Oct 12 09:07 ETSource: USA Today
The wire
- 01Arbor says its GLP-1 medication plans start at $99 per month.
- 02Low-priced direct-to-consumer GLP-1 programs continue to pressure pharmacy and clinic pricing for semaglutide and tirzepatide.
- 03The item does not specify which drug, dose, source pharmacy or whether prices rise at higher doses.
From the source
Read at usatoday.comAffordable GLP-1 medications? Arbor's plans start at $99 a month
